Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Discuss persistent symptoms with your clinician
Our study found that over an average follow-up of 2 years, GLP-1 RA use was associated with a significantly lower incidence of cancers directly fueled by excess body weight
Journal of Pain Research, 18, 14791489
The researchers suggest that GLP-1 medications may provide a double benefit: potentially slowed cancer growth reduced risk of heart attack and stroke, which also improves survival The results were published in Cancer Investigation and are in line with other research on GLP-1 and cancer
Syra Hanif takes the guesswork out of peptide therapy
US$ 22.76
US$ 21.75
![GLP-1 Suitability Panel — At-Home Metabolic Test [Weight Insights]](https://cdn.shopify.com/s/files/1/0448/1033/8466/files/glp-1-1.jpg?v=1761798026)
US$ 27.71
US$ 23.89
US$ 23.75
